Cargando…

Rituximab, but not other biologics, impairs humoral immunity in patients with rheumatoid arthritis—a study using CoVariant protein arrays

OBJECTIVES: RA is an autoimmune disease characterized by chronic inflammation and joint destruction. Biologics are crucial to achieving treat-to-target goals in patients with RA. The global spread and continuous variation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) necessitate th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Wei-Hsun, Du, Pin-Xian, Tsai, Pei-Shan, Keskin, Batuhan Birol, Su, Wen-Yu, Lee, Nan-Yao, Ko, Wen-Chien, Lin, Pei-Chun, Shih, Hsi-Chang, Weng, Meng-Yu, Syu, Guan-Da
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Concise Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10627286/ https://www.ncbi.nlm.nih.gov/pubmed/37937178 http://dx.doi.org/10.1093/rap/rkad085

Ejemplares similares

Profiling Humoral Immunity After Mixing and Matching COVID-19 Vaccines Using SARS-CoV-2 Variant Protein Microarrays
por: Kuo, Ho-Chang, et al.
Publicado: (2023)

Development of SARS-CoV-2 variant protein microarray for profiling humoral immunity in vaccinated subjects
por: Ho, Tzong-Shiann, et al.
Publicado: (2022)

Therapeutic use of red blood cells and platelets derived from human cord blood stem cells
por: Xie, Xiaoyan, et al.
Publicado: (2021)

The treatment of Merkel cell carcinoma with immune checkpoint inhibitors: implications for patients with rheumatoid arthritis
por: Klee, Gina, et al.
Publicado: (2021)

Reduced cognitive ability in people with rheumatoid arthritis compared with age-matched healthy controls
por: Gwinnutt, James M, et al.
Publicado: (2021)

Cellular and Molecular Targets of Extracellular Vesicles from Mesenchymal Stem/Stromal Cells in Rheumatoid Arthritis
por: Alcaraz, María José, et al.
Publicado: (2022)

Time to Include Fine Specificity Anti‐Citrullinated Protein Antibodies in the Routine Diagnosis and Management of Rheumatoid Arthritis?
por: Schwenzer, Anja, et al.
Publicado: (2019)

Extra-articular findings with FDG-PET/CT in rheumatoid arthritis patients: more harm than benefit
por: Ulijn, Evy, et al.
Publicado: (2022)

Burden of rheumatoid arthritis among US Medicare population: co-morbidities, health-care resource utilization and costs
por: Chen, Chieh-I, et al.
Publicado: (2018)

Rheumatoid arthritis patients with predominantly tender joints rarely achieve clinical remission despite being in ultrasound remission
por: Hammer, Hilde Berner, et al.
Publicado: (2021)

Mindfulness-based stress reduction to improve depression, pain and high patient global assessment in controlled rheumatoid arthritis
por: Gaboury, Isabelle, et al.
Publicado: (2022)

Primary care challenges in diagnosing and referring patients with suspected rheumatoid arthritis: a national cross-sectional GP survey
por: Scott, Ian C, et al.
Publicado: (2018)

Evaluating the efficacy of upadacitinib in patients with moderate rheumatoid arthritis: a post-hoc analysis of the SELECT phase 3 trials
por: Conaghan, Philip G, et al.
Publicado: (2023)

Impact of the COVID-19 pandemic on patients with rheumatoid arthritis: data from the Ontario Best Practices Research Initiative (OBRI)
por: Wong-Pack, Matthew, et al.
Publicado: (2023)

Use of rheumatoid arthritis impact of disease (RAID) in routine care; identification of DAS28 remission and unmet patient-reported outcomes
por: Mistry, Jatin, et al.
Publicado: (2020)

Sarilumab reduces disease activity in rheumatoid arthritis patients with inadequate response to janus kinase inhibitors or tocilizumab in regular care in Germany
por: Tony, Hans-Peter, et al.
Publicado: (2022)

Incidence of Disease Flare After BNT162b2 Coronavirus Disease 2019 Vaccination in Patients With Rheumatoid Arthritis in Remission
por: Bixio, Riccardo, et al.
Publicado: (2021)

Should quantitative assessment of rheumatoid arthritis include measures of joint damage and patient distress, in addition to measures of apparent inflammatory activity?
por: Pincus, Theodore, et al.
Publicado: (2022)

Direct Lineage Reprogramming for Induced Keratinocyte Stem Cells: A Potential Approach for Skin Repair
por: Lin, Haohui, et al.
Publicado: (2023)

Beyond the visual analog scale: results from a multimodal pain assessment pilot study in first‐degree relatives of patients with rheumatoid arthritis
por: McDougall, Cairistin, et al.
Publicado: (2022)

Mycobacterium tuberculosis found at both skin lesions and Mantoux testing site in a patient with erythema induratum of Bazin
por: Xu, Hui, et al.
Publicado: (2017)

Comparison of Renal Responses Between Continuous Mycophenolate Mofetil and Conversion from Mycophenolate Mofetil to Enteric-Coated Mycophenolate Sodium in Lupus Nephritis
por: Liao, Yu-Wan, et al.
Publicado: (2022)

Rituximab: Humoral immunodeficiency: case report
Publicado: (2021)

Mesenchymal Stromal Cell Mitochondrial Transfer as a Cell Rescue Strategy in Regenerative Medicine: A Review of Evidence in Preclinical Models
por: Tan, Yu Ling, et al.
Publicado: (2022)

Three-Dimensional Spheroid Culture of Human Mesenchymal Stem Cells: Offering Therapeutic Advantages and In Vitro Glimpses of the In Vivo State
por: Yen, B Linju, et al.
Publicado: (2023)

Humoral response to coronavirus disease-19 vaccines is dependent on dosage and timing of rituximab in patients with rheumatoid arthritis
por: van der Togt, Céleste J T, et al.
Publicado: (2022)

The Provision of Dental Care to COVID-19 Survivors: A Concise Review
por: Ngeow, Wei Cheong, et al.
Publicado: (2022)

Vacuum exhausted isolation locker (VEIL) to reduce inpatient droplet/aerosol transmission during COVID-19 pandemic
por: Gopesh, Tilvawala, et al.
Publicado: (2021)

Persistence and Waning of Natural SARS-CoV-2 Antibodies Over 18 Months: Long-Term Durability of IgG Humoral Response in Healthcare Workers
por: Varona, Jose F., et al.
Publicado: (2022)

Rituximab for Rheumatoid Arthritis
por: Cohen, Marc D., et al.
Publicado: (2015)

Direct cellular reprogramming enables development of viral T antigen–driven Merkel cell carcinoma in mice
por: Verhaegen, Monique E., et al.
Publicado: (2022)

Mesenchymal Stem/Stromal Cell Senescence: Hallmarks, Mechanisms, and Combating Strategies
por: Weng, Zhijie, et al.
Publicado: (2022)

Neuronal cell‐based medicines from pluripotent stem cells: Development, production, and preclinical assessment
por: Sun, Yun, et al.
Publicado: (2021)

Hematopoietic stem cell‐ and induced pluripotent stem cell‐derived CAR‐NK cells as reliable cell‐based therapy solutions
por: Arias, Jonathan, et al.
Publicado: (2021)

Usefulness of 2‐D shear wave elastography for the diagnosis of inguinal lymph node metastasis of malignant melanoma and squamous cell carcinoma
por: Kawahara, Yu, et al.
Publicado: (2020)

Neural Stem/Progenitor Cell Transplantation in Parkinson’s Rodent Animals: A Meta-Analysis and Systematic Review
por: Zheng, Yifeng, et al.
Publicado: (2022)

Pneumocystis pneumonia and rheumatic disease: diagnostic potential of circulating microbial cell-free DNA sequencing
por: Li, Jia, et al.
Publicado: (2021)

Management of COVID-19 patients with chronic liver diseases and liver transplants
por: Hu, Xinyu, et al.
Publicado: (2022)

A multicenter analysis of inpatient antibiotic use during the 2015–2019 influenza seasons in the United States: Untapped opportunities for antimicrobial stewardship
por: Yu, Kalvin C., et al.
Publicado: (2022)

Mesenchymal Stem Cell Utilization for In Vitro Donor Liver Machine Perfusion Preservation: Current Status and Future Directions
por: Fu, Yu, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_g0iltn3n1ooiv5anqe4n5sf5il